Bilcare Ag To Acquire Ineos' Global Films Business For Eur100 Million

< BACK TO FINANCE starstarstarstarstar   Business - Finance Press Release
2nd August 2010, 11:24pm - Views: 1072






Business Finance INEOS Group 2 image





MEDIA RELEASE PR40652


Bilcare AG to Acquire INEOS' Global Films Business for EUR100 Million


LAUSANNE, Switzerland, August 2 /PRNewswire-AsiaNet/ --


    INEOS Group has today entered into a binding agreement for the sale of

its Global Films business to Bilcare AG, one of the world's leading providers

of research led packaging to the global pharmaceuticals industry, for

approximately EUR100 million. The agreement brings together complimentary

capabilities and synergy's of two leading global businesses.


    INEOS Films is a leader in the Pharma, Specialties, Cards and Packaging

Films business; Bilcare is the foremost solution provider of innovative

packaging to the global pharmaceuticals for their brand safety and growth.


    The deal comprises the business, assets and personnel related to INEOS'

Films operations located in North America, Europe, and Asia.


    Iain Hogan, CEO INEOS Films, warmly welcomed the announcement. "I am very

excited by the potential created by the combination of these two companies.

Bringing together Bilcare's research and development focus with our own broad

production and application knowledge provides a very strong strategic fit.


    "Whilst performing well, the INEOS Films business is no longer core to

the INEOS Group as the company focuses its attention on its large-scale

petrochemicals businesses. This agreement with Bilcare will put INEOS Films

assets and people at the centre of a new business with the innovation and

drive necessary for it to grow and further develop, which is good for the

business and its customers globally."


    INEOS Films is a leading global producer of high quality polymer films

built on expertise and innovation. The company plays a major role in the

world of pharmaceutical blister packaging, films for printing and decoration,

shrink film for sleeves, capsules and plastic credit cards. The company

employs around 1300 people across manufacturing sites in Germany, Italy,

India and North America and has a turnover of around EUR240 million.


    Mohan Bhandari, Chairman, Bilcare Limited said, "This acquisition is a

paradigm shift in the pharma packaging space & a significant step towards

creating a customer centric company to deliver path breaking innovations and

establish global leadership".


    The newly appointed Executive Chairman of Bilcare AG, Dr. Heinz Gaertner

said, "This transaction presents a unique opportunity and enhances our offer

to apply our innovation led approach to a broad range of industries,

currently served by INEOS Films, particularly in Europe and USA."


    The transaction inter alia, is proposed to be effected through a merger

process in Germany, in relation to the German company and its subsidiaries.

The transaction is expected to be completed at the end of August, subject to

necessary regulatory filings and approvals, including German Court and

approvals under applicable antitrust laws and regulations.


    Note:


    INEOS (http://www.ineos.com) is one of the world's leading chemical

companies; a leading manufacturer of petrochemicals, specialty chemicals and

oil products. Comprising 15 businesses, with a production network spanning 60

manufacturing facilities in 13 countries, the company produces more than 40

million tonnes of petrochemicals, 20 million tons per annum of crude oil

refined products (fuels). INEOS employs 15,000 people and had sales of

$28.6bn in 2009.


    Bilcare (http://www.bilcare.com) Bilcare Ltd. (BSE code 526853) is an

international, integrated service provider to the global pharmaceutical

industry offering Pharma packaging & research, global clinical trial supplies

services and Bilcare Technologies offering nonClonableID(TM) identification,

authentication, secure track-n-trace anti-counterfeiting technology. Bilcare

operates state-of-the-art manufacturing and research facilities in India,

Singapore, USA and UK and has regional offices in Brazil, Germany, China and

Australia. Bilcare provides solutions that address many of the industry's key

concerns including counterfeit drugs, compliance, costs, communication and

convenience.


    Further information contact:


    Richard Longden - INEOS - Tel: +44(0)7710-371998


    Jaydip Chowdhury - Bilcare - Tel: +91-99224-29719


    Source: INEOS Group


AsiaNet releases please visit http://www.asianetnews.net






news articles logo NEWS ARTICLES
Contact News Articles |Remove this article